• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过 circ_0008898/miR-211-5p/HMGB1 轴抑制肺纤维化进展。

Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR-211-5p/HMGB1 axis.

机构信息

Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou City, China.

出版信息

Chem Biol Drug Des. 2024 Mar;103(3):e14508. doi: 10.1111/cbdd.14508.

DOI:10.1111/cbdd.14508
PMID:38514749
Abstract

Pulmonary Fibrosis (PF) is a fatal lung disease with complicated pathogenesis. Astragaloside IV (ASV) has been discovered to alleviate PF progression, and the potential molecular mechanism of ASV in the development of PF need to be further clarified. Bleomycin (BLM) was used to construct PF in vivo model. Expression levels of circ_0008898, miR-211-5p, high mobility group protein B1 (HMGB1), alpha smooth muscle Actin (α-SMA) and Collagen I were examined by Quantitative real time polymerase chain reaction (qRT-PCR) and western blot. Cell survival was analyzed using Cell Counting Kit-8 (CCK-8) and EdU (5-ethynyl-2'-deoxyuridine) assay. The invasion abilities were investigated by transwell assay. The levels of inflammatory factors were tested via using Enzyme-linked immunosorbent assay (ELISA). The relationship between circ_0008898 or HMGB1 and miR-211-5p was identified by dual-luciferase reporter assay. The results showed that ASV attenuated BLM-induced pulmonary fibrosis in vivo. In vitro study, ASV alleviated TGF-β1-induced fibrogenesis in HFL1 cells. Circ_0008898 was increased in TGF-β1-induced HFL1 cells. ASV-induced impacts were abrogated by circ_0008898 overexpression in TGF-β1-induced HFL1 cells. Mechanistically, circ_0008898 competitively bound to miR-211-5p to increase the expression of its target HMGB1. MiR-211-5p deficiency rescued ASV-mediated effects in TGF-β1-induced HFL1 cells. In addition, HMGB1 overexpression partially overturned circ_0008898 interference-induced impacts in HFL1 cells upon TGF-β1 treatment. In conclusion, our work manifested that ASV hindered PF process by mediating the circ_0008898/miR-211-5p/HMGB1 network.

摘要

肺纤维化(PF)是一种具有复杂发病机制的致命肺部疾病。已发现黄芪甲苷(ASV)可减轻 PF 的进展,需要进一步阐明 ASV 在 PF 发展中的潜在分子机制。博来霉素(BLM)用于构建体内 PF 模型。通过定量实时聚合酶链反应(qRT-PCR)和蛋白质印迹法检测 circ_0008898、miR-211-5p、高迁移率族蛋白 B1(HMGB1)、α平滑肌肌动蛋白(α-SMA)和 I 型胶原的表达水平。使用细胞计数试剂盒-8(CCK-8)和 5-乙炔基-2'-脱氧尿苷(EdU)测定法分析细胞存活率。通过 Transwell 测定法研究细胞侵袭能力。通过酶联免疫吸附测定法(ELISA)测试炎症因子水平。通过双荧光素酶报告基因检测法鉴定 circ_0008898 或 HMGB1 与 miR-211-5p 之间的关系。结果表明,ASV 可减轻 BLM 诱导的体内肺纤维化。在体外研究中,ASV 减轻 TGF-β1 诱导的 HFL1 细胞纤维化。TGF-β1 诱导的 HFL1 细胞中 circ_0008898 增加。在 TGF-β1 诱导的 HFL1 细胞中过表达 circ_0008898 可消除 ASV 诱导的作用。机制上,circ_0008898 竞争性结合 miR-211-5p 以增加其靶标 HMGB1 的表达。miR-211-5p 缺陷挽救了 TGF-β1 诱导的 HFL1 细胞中 ASV 介导的作用。此外,HMGB1 过表达部分逆转了 TGF-β1 处理后 HFL1 细胞中转录本 0008898 干扰诱导的影响。总之,我们的工作表明,ASV 通过介导 circ_0008898/miR-211-5p/HMGB1 网络来抑制 PF 进程。

相似文献

1
Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR-211-5p/HMGB1 axis.黄芪甲苷通过 circ_0008898/miR-211-5p/HMGB1 轴抑制肺纤维化进展。
Chem Biol Drug Des. 2024 Mar;103(3):e14508. doi: 10.1111/cbdd.14508.
2
Circ_0035796 depletion inhibits transforming growth factor-β1-induced pulmonary fibrosis in a miR-150-5p/L1CAM-dependent manner.Circ_0035796 耗竭以 miR-150-5p/L1CAM 依赖性方式抑制转化生长因子-β1 诱导的肺纤维化。
Autoimmunity. 2023 Dec;56(1):2250099. doi: 10.1080/08916934.2023.2250099. Epub 2023 Oct 11.
3
Circ_0007535 upregulates TGFBR1 to promote pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering miR-18a-5p.Circ_0007535 通过隔离 miR-18a-5p 而上调 TGFBR1 促进 TGF-β1 处理的肺成纤维细胞中的肺纤维化。
Autoimmunity. 2023 Dec;56(1):2259128. doi: 10.1080/08916934.2023.2259128. Epub 2023 Sep 19.
4
Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.黄芪甲苷通过靶向 circ_0000231/miR-135a-5p/CLIC4 轴缓解动脉粥样硬化体外 AS 细胞模型。
Mol Cell Biochem. 2021 Apr;476(4):1783-1795. doi: 10.1007/s11010-020-04035-8. Epub 2021 Jan 13.
5
miR-627/HMGB1/NF-κB regulatory loop modulates TGF-β1-induced pulmonary fibrosis.miR-627/HMGB1/NF-κB 调控环路调节 TGF-β1 诱导的肺纤维化。
J Cell Biochem. 2019 Mar;120(3):2983-2993. doi: 10.1002/jcb.27038. Epub 2018 Dec 9.
6
Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.黄芪甲苷通过调节 TGF-β1 依赖性上皮-间充质转化抑制博来霉素诱导的肺纤维化。
J Cell Mol Med. 2018 Sep;22(9):4354-4365. doi: 10.1111/jcmm.13725. Epub 2018 Jul 4.
7
Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation.环状CSPP1敲低通过miR-493-5p释放介导的HMGB1下调抑制肝癌进展。
Cell Signal. 2021 Oct;86:110065. doi: 10.1016/j.cellsig.2021.110065. Epub 2021 Jun 26.
8
LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway.长链非编码 RNA NEAT1 通过 miR-9-5p 和 TGF-β 信号通路调节肺纤维化。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8483-8492. doi: 10.26355/eurrev_202008_22661.
9
Hsa_circ_0031891 targets miR-579-3p to enhance HMGB1 expression and regulate PDGF-BB-induced human aortic vascular smooth muscle cell proliferation, migration, and dedifferentiation.Hsa_circ_0031891 通过靶向 miR-579-3p 增强 HMGB1 表达并调节 PDGF-BB 诱导的人主动脉血管平滑肌细胞增殖、迁移和去分化。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):1093-1104. doi: 10.1007/s00210-023-02663-7. Epub 2023 Aug 22.
10
Astragaloside IV regulates circ_0001615 and miR-873-5p/LASP1 axis to suppress colorectal cancer cell progression.黄芪甲苷通过调控 circ_0001615 和 miR-873-5p/LASP1 轴抑制结直肠癌细胞的进展。
Chem Biol Drug Des. 2024 Jan;103(1):e14423. doi: 10.1111/cbdd.14423.

引用本文的文献

1
Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies.黄芪甲苷IV对肺纤维化的治疗作用及潜在机制:一项临床前研究的系统评价和荟萃分析
Front Pharmacol. 2025 Jul 31;16:1564290. doi: 10.3389/fphar.2025.1564290. eCollection 2025.
2
Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis.重新审视微小RNA在特发性肺纤维化发病机制中的作用。
Front Cell Dev Biol. 2024 Oct 16;12:1470875. doi: 10.3389/fcell.2024.1470875. eCollection 2024.